Reagenzgläser

Vesalius Biocapital

A European life sciences venture capital investor

.

About us

News

Vesalius News

01/24/2023

Memo Therapeutics: Positive Phase I Data

12/14/2022

CatalYm: Visugromab Development

11/22/2022

CatalYm: EUR 50 Million Financing